Timil Patel

4PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 04, 2025
Adoption of Decentralized Trial Elements in Cancer Clinical Trials Supporting FDA Approvals during COVID-19.

Timil H Patel, Amy Corneli, Pamela Balcazar

|Jun 10, 2024
Reflections and Roadmaps: Career Development beyond the FDA-AACR Oncology Educational Fellowship.

Timil Patel, Chris Chen, Samer Al Hadidi

|Sep 07, 2023
FDA Approval Summary: Tremelimumab in Combination with Durvalumab for the Treatment of Patients with Unresectable Hepatocellular Carcinoma.

Timil H Patel, Jamie R Brewer, Jiaxin Fan

|Oct 07, 2022
FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement.

Timil H Patel, Leigh Marcus, M Naomi Horiba

Pageof 1